Silvano Lattanzi USA New York City, NY - 10021

Silvano Lattanzi USA is categorized under Orthopedic Shoes in New York City, NY and active since 2002.

Silvano Lattanzi USA was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Shoes business, which does work in the B2C market, and is classified as a Orthopedic Shoes, under code number 4482100 by the NAICS.

If you are seeking more information, feel free to contact Silvano Lattanzi, Owner at the company’s single location by writing to 905 Madison Avenue Front 1, New York City, New York NY 10021 or by phoning (212) 734-2962. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Silvano Lattanzi USA
Contact Person: Silvano Lattanzi, Owner
Address: 905 Madison Avenue Front 1, New York City, New York 10021
Phone Number: (212) 734-2962
Website Address: silvanolattanzi.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Orthopedic Shoes
SIC Code: 5661
NAICS Code: 4482100
Share This Business:

Silvano Lattanzi USA was started in 2002 to provide professional Orthopedic Shoes under the SIC code 5661 and NAICS code 4482100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Silvano Lattanzi, Owner for inquiries that concern Silvano Lattanzi USA by calling the company number (212) 734-2962, as your correspondence is most welcome. Additionally, the physical location of the single location of Silvano Lattanzi USA can be found at the coordinates 40.771915,-73.965299 as well as the street address 905 Madison Avenue Front 1 in New York City, New York 10021.

For its online presence, you may visit Silvano Lattanzi USA’s website at silvanolattanzi.com and engage with its social media outlets through on Twitter and on Facebook.